UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004485
Receipt number R000005302
Scientific Title Dynamic stability training can promote quiet standing control in neuropathic patients with type 2 diabetes
Date of disclosure of the study information 2010/11/06
Last modified on 2010/10/31 22:17:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Dynamic stability training can promote quiet standing control in neuropathic patients with type 2 diabetes

Acronym

Dynamic stability training can promote quiet standing control in neuropathic patients with type 2 diabetes

Scientific Title

Dynamic stability training can promote quiet standing control in neuropathic patients with type 2 diabetes

Scientific Title:Acronym

Dynamic stability training can promote quiet standing control in neuropathic patients with type 2 diabetes

Region

Asia(except Japan)


Condition

Condition

Type 2 Diabetes neuropathy

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

context specific balance rehabilitation of type 2 diabetese neuropathic patients by provoking somatosensory information with respect to the guidance effect of external visual biofeedback

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Standing balance control scores were acquired from Biodex stability system and fluctuations of COP signals. Repeated measure ANOVA was performed to test mean differences and then compared with the LSD test. Paired T-test was used for comparing the pure effect of trainings. Our investigation showed statistical improvement in the results of Biodex stability scores and force platform mediolateral sway.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment

Interventions/Control_1

In this study, there was a 3-week baseline with evaluation after 3 weeks (time effect) followed by training over 3 weeks with re-evaluation (training effect). First evaluation included descriptive information such as age, sex, height, weight, BMI, Valk score, diabetic history and postural strategy assessments by biodex stability scores (BSS) and force platform assessments. After the first 3-week, patients were evaluated for the second time by Valk score and postural strategy assessments. Third evaluation was again included Valk score and postural strategy assessments after the patients had been trained by biodex balance exercises in the second 3-week. In this study, force platform evaluations were included, in order to evaluate DN patients` postural strategy with the more precise assessment other than the device that they were trained with.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients` neuropathies were assessed by nerve conduction velocity tests.Patient inclusion criteria included patient age (between 40-70 years old), duration of time suffering from controlled type 2 diabetes (more than 5 years. Patient FBS test results (greater than 110mg/dl), Valk neuropathy score (greater than 2) and Snellen chart score (greater than 16/20)

Key exclusion criteria

Participants were excluded from this study if they had retinopathy, scars under their feet, BMI score greater than 40, hypotension, autonomic neuropathy and any orthopedic or neurologic impairment related to balance performance. And they were also excluded if they had prior experience of balance trainings with biodex stability system (BSS), force platform and the task

Target sample size

19


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hoda Salsabili

Organization

Tarbiat Modares University

Division name

Physiotherapy

Zip code


Address

Jalal Al Ahmad Street, Gisha Bridge

TEL

+81-098-021-77927852

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hoda Salsabili

Organization

Tarbiat Modares University

Division name

Physiotherapy

Zip code


Address

Jalal Al Ahmad Street, Gisha Bridge

TEL

+81-098-021-77927852

Homepage URL


Email

h.salsabili@gmail.com


Sponsor or person

Institute

Tarbiat Modares University

Institute

Department

Personal name



Funding Source

Organization

Tarbiat Modares University

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 11 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 11 Month 16 Day

Date of IRB


Anticipated trial start date

2010 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 10 Month 31 Day

Last modified on

2010 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005302